Drug Trial Radar · NCT03573297
A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features
Last checked: Nov 20, 2026Latest source record: Sep 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
901
Actual
Start
Jun 15, 2018
Primary completion
Sep 5, 2022
Study completion Sep 5, 2022
Sponsor
- Lead sponsor
- AbbVieAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Jun 29, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
1\) To evaluate the efficacy and safety of cariprazine at a target dose of 3.0 mg/day compared with placebo in prevention of relapse in patients with bipolar I disorder whose current episode (i.e. index episode) is manic or depressive, with or without mixed features; 2) To evaluate the efficacy and safety of cariprazine at a target dose of 1.5 mg/day compared with placebo in prevention of relapse in patients with bipolar I disorder whose current episode (i.e. index episode) is manic or depressive, with or without mixed features who were initially stabilized on a target dose of 3.0 mg/day
Conditions
- Bipolar I Disorder
- Mania
- Depression
Interventions
CariprazineDrug
Cariprazine capsules, oral administration, once daily
PlaceboDrug
Matching placebo capsules, oral administration, once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to First Relapse of Any Mood Episode During the Double-Blind Treatment PeriodTime frame: From Week 16 to Week 55
Locations
108 sites in 11 countries. Site status is shown where the registry gives one.
Woodland International Research Group /ID# 232932
Little Rock, Arkansas
Woodland Research Northwest, LLC /ID# 232982
Rogers, Arkansas
California Pharmaceutical Research Institute Inc. /ID# 232745
Anaheim, California
Advanced Research Center /ID# 233120
Anaheim, California
CI Trials /ID# 232642
Bellflower, California
Synexus Clinical Research US Inc. /ID# 232743
Cerritos, California
ATP Clinical Research, Inc /ID# 232979
Costa Mesa, California
ProScience Research Group /ID# 232945
Culver City, California
Collaborative Neuroscience Research - Orange County /ID# 233077
Garden Grove, California
Behavioral Research Specialists, LLC /ID# 232980
Glendale, California
Omega Clinical Trials LLC /ID# 233150
La Habra, California
Synergy San Diego /ID# 232740
Lemon Grove, California
Alliance for Research - Long Beach /ID# 232926
Long Beach, California
NRC Research Institute /ID# 232741
Orange, California
CNRI-San Diego /ID# 232748
San Diego, California
Artemis Institute for Clinical Research /ID# 233151
San Marcos, California
Artemis Institute for Clinical Research /ID# 233152
San Marcos, California
Collaborative Neuroscience Research LLC /ID# 232750
Torrance, California
Duplicate_MCB Clinical Research Centers LLC /ID# 232838
Colorado Springs, Colorado
Velocity Clinical Research - Hallandale Beach /ID# 232647
Hallandale, Florida
Research Centers of America - Hollywood FL /ID# 232649
Hollywood, Florida
CNS Healthcare - Jacksonville /ID# 233160
Jacksonville, Florida
Meridien Research /ID# 232941
Maitland, Florida
Miami Lakes Medical Research /ID# 232826
Miami Lakes, Florida
University of South Florida /ID# 233093
Tampa, Florida
Synexus Clinical Research, Inc /ID# 232950
Atlanta, Georgia
Atlanta Center for Medical Research /ID# 232832
Atlanta, Georgia
CenExcel iResearch LLC /ID# 233045
Decatur, Georgia
Atlanta Behavioral Research, LLC /ID# 232935
Dunwoody, Georgia
NeuroPsychiatric Research Practice & Associate LTD /ID# 232840
Winfield, Illinois
Louisiana Clinical Research /ID# 232685
Shreveport, Louisiana
CBH Health LLC /ID# 232699
Gaithersburg, Maryland
St. Charles Psychiatric Associates - Midwest Research Group /ID# 232709
Saint Charles, Missouri
Duplicate_Altea Research Institute /ID# 232784
Las Vegas, Nevada
Hassman Research Institute /ID# 233088
Berlin, New Jersey
Neurobehavioral Research Inc /ID# 232791
Cedarhurst, New York
New Hope Clinical Research Inc. /ID# 232716
Charlotte, North Carolina
Richard Weisler MD, PA & Assoc /ID# 233049
Raleigh, North Carolina
Clinical Inquest Center Ltd /ID# 233043
Beavercreek, Ohio
DUPLICATE_The Ohios State University Department of Psychiatry /ID# 232739
Columbus, Ohio
Showing 40 of 108 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.